Cambridge, UK – Fluidic Analytics Ltd has raised $31 million to continue developing its transformational products for characterising proteins and their behaviour. The proceeds of the financing will be used to continue the commercial roll-out of the company’s lab-tools pipeline and to develop further high-value clinical applications of its technology. Proteins and their behaviour are crucial […]

The Government of Canada awards $1M in funding to this Québec City business Québec City, Quebec – Canada Economic Development for Quebec Regions (CED) SiliCycle is a leader in the development, manufacturing and commercialization of innovative silica-based products. The company wants to diversify its markets through the development and commercialization of products resulting from the […]

New grants support FDA’s GDUFA priorities of expanding bioequivalence methods for topical dermatological products and improving PBPK models of drug absorption via complex delivery routes  PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced that it has been awarded two new dermal virtual bioequivalence grants […]

SAN FRANCISCO–Trace Genomics®, a San Francisco Bay area startup developing revolutionary, AI-enabled diagnostic tools for farmers to increase yields and reduce costs, has closed a $13 million Series A round. Trace Genomics has launched the first scalable soil microbiome test to enable the early prediction of soil diseases, soil health and crop quality. Every tablespoon […]

SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. All of the shares of common stock are […]

We’re excited to make two major announcements today. We have closed a $110M Series C investmentround led by Founders Fund and we have added Dr. Matthew Porteus, a pioneer in cell therapies, to our advisory board. Since the start of our journey at Synthego, we’ve been committed to making state-of-the-art genome engineering tools accessible to researchers […]

DANVILLE, VA – The Launch Place has been on a mission since 2013 to help early stage startups with strong teams and impactful business models get a product to market. The Launch Place announces today that biotech startup CytoRecovery will be the first to receive a $75,000 investment from The Launch Place Pre-Seed Fund 2, which was […]

IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that Amgen (NASDAQ:AMGN) has announced an equity investment of £50 million into portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore” or “the Company”).   The investment will be effected through the purchase of £50 million of existing ordinary […]

Five new genomics startups focused on therapeutics, diagnostics and informatics Illumina Accelerator welcomes five new startups to its eighth investment cycle. The genomics-based company creation engine focuses on building early-stage genomics companies and helps startups validate and create next-generation sequencing applications and bring those products to market. During the six-month cycle, Illumina Accelerator offers the […]

Financing will also be used to drive R&D and further expand commercial activities for digital cell biology worldwide Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the completion of a $95 million financing led by Nikon and backed by existing investors Sequoia Capital, Walden-Riverwood Ventures, Black Diamond Ventures, […]